Ann: Trading Halt, page-18

Highlights:  Avecho has announced formal ethics approval of its pivotal Phase III clinical trial testing its oral CBD softgel capsule for insomnia.  The study is the largest randomised, placebo controlled study being undertaken in Australia to support registration of cannabidiol as an over-the-counter medicine with the Therapeutic Goods Administration (TGA)  The study has been purposefully designed to produce relevant clinical evidence, which is applicable to support product registration with key global regulatory bodies including the TGA, the FDA and the EMEA.